Sartorius (OTCMKTS:SARTF – Get Free Report) will likely be announcing its resultson Thursday, April 23rd. Analysts expect the company to announce earnings of $1.37 per share and revenue of $932.2810 million for the quarter.
Sartorius Stock Performance
Shares of Sartorius stock opened at $226.33 on Thursday. Sartorius has a 12-month low of $165.00 and a 12-month high of $226.33. The stock has a market capitalization of $7.75 billion, a P/E ratio of 105.27 and a beta of 0.98. The company has a 50-day simple moving average of $226.33 and a 200 day simple moving average of $218.92. The company has a quick ratio of 0.49, a current ratio of 0.95 and a debt-to-equity ratio of 0.89.
Sartorius Company Profile
Sartorius AG, trading in the U.S. over the counter under the symbol SARTF, is a Germany-based provider of laboratory and bioprocessing equipment for the pharmaceutical, biotechnology and research industries. The company is organized into two core divisions: Bioprocess Solutions, which focuses on single-use consumables, filtration technologies and upstream and downstream processing systems; and Lab Products & Services, which supplies laboratory instruments, consumables and services, including balances, pipettes, cell counting systems and water purification units.
The Bioprocess Solutions segment serves customers engaged in the development and manufacture of biopharmaceuticals, vaccines and advanced therapies.
Further Reading
Receive News & Ratings for Sartorius Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sartorius and related companies with MarketBeat.com's FREE daily email newsletter.
